To include your compound in the COVID-19 Resource Center, submit it here.

Azathioprine regulatory update

FDA issued a safety review update that it continues to receive reports of hepatosplenic T cell lymphoma (HSTCL) primarily in adolescents and young adults

Read the full 249 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE